Advertisement
Home Tags Prescription Drugs

Tag: Prescription Drugs

The incidence of cytomegalovirus infection/disease is reduced in de novo kidney transplant recipients receiving reduced dose tacrolimus and everolimus

Reduced-Dose Tacrolimus, Everolimus Cuts CMV Infection

0
Findings in de novo kidney recipients receiving no pharmacologic CMV prophylaxis
In adults with episodic migraine

Simvastatin, Vitamin D3 Combo Helps Prevent Migraines

0
Treatment effective for preventing headache in adults with episodic migraine
Patients taking β-blockers may face heightened risks of cardiovascular complications during non-cardiac surgeries

β-Blockers May Up Risk of Surgical Complications for Some

0
Heightened risks of cardiovascular complications seen during non-cardiac surgeries
For patients with type 2 diabetes mellitus treated with metformin

Add-On Sitagliptin Cuts Risk of Insulin Initiation in T2DM

0
Risk of insulin initiation lower for sitagliptin versus sulphonylurea as add-on to metformin
A new treatment for melanoma that combines two cancer drugs has been approved by the U.S. Food and Drug Administration. The therapy for advanced melanoma includes the drugs Yervoy (ipilimumab) and Opdivo (nivolumab)

FDA Approves New Combo Therapy for Melanoma

0
Yervoy and Opdivo previously approved individually to treat melanoma
Two experimental drugs

Two Experimental Drugs Promising for Psoriasis Rx

0
Targeted therapies produce significant results, researchers say
Routine use of dual antiplatelet therapy beyond six months after second generation drug-eluting stent implantation yields mixed clinical results

Long Duration Dual Antiplatelet Treatment Increases Bleeding

0
However, leads to small decrease in stent thrombosis, myocardial infarction after stent
Two newer classes of drugs

Angioedema Induced by New Classes of Drugs

0
Angioedema occurs with DPP IV or neprilysin blockers; bradykinin contribution seems likely
In a recent study

New Treatment Option for Some With Metastatic Lung Cancer

0
Nivolumab found most effective in tumors expressing programmed death-ligand 1
For patients with heart failure

β-Blocker Dose More Impactful Than Heart Rate in Heart Failure

0
BB dose has greater impact than lower heart rate in patients with heart failure from HF-ACTION trial